Putting the Power of Information in the Hands of Allergy Sufferers

Putting the Power of Information in the Hands of Allergy Sufferers

ID: 47967

REACTINE(R) Launches New Allergy Forecast at the Height of Ragweed Season


(firmenpresse) - TORONTO, ONTARIO -- (Marketwire) -- 08/18/11 -- Editors Note: There are three photos and three fact sheets associated with this press release.

As many as nine million allergy sufferers across Canada now have a new tool to tackle hay fever season. Launched today, the for iPhone®, is the first and only iPhone app in Canada that provides three-day allergy and weather forecasts. Now sufferers can take control of their allergies by planning ahead, knowing when allergy symptoms are likely to be at their worst.

"We keep hearing patients complain of worsening allergy symptoms that are lasting for a longer period of time," says , Professor of Medicine, Division of Clinical Immunology and Allergy, McMaster University. "What many people don't realize is how factors such as changing weather patterns can have an impact on how people are experiencing their symptoms."

The effect of environmental issues, like climate change on pollen counts, have been recently documented. A found an extended allergy season in several parts of North America, including regions in Canada. In the most-affected areas, ragweed season has been extended by as long as a month.

While these environmental factors related to allergies are difficult to control, people can control how they manage their allergy symptoms. The lets allergy sufferers know when their symptoms are likely to be at their worst, due to high airborne pollen counts.

is serious about allergies. Through the , the power to manage allergy symptoms is now in the hands of those who suffer. By providing information three days in advance, allergy sufferers know what they need to do to appropriately plan ahead.

About the REACTINE® Allergy Forecast

The is powered by Ottawa-based , a leader in aerobiology specializing in outdoor aeroallergens. is the definitive source of pollen and fungal spore levels in Canada and uses professionally-trained experts to ensure the accuracy of its results.





has stations for 30 major centres across Canada. Samples are collected for 24 hours and couriered to the laboratory in Ottawa where they are analyzed through optical microscopy. Each particle on a sample is identified individually and tallied, and through statistical formulas, the counts are converted to particles per cubic meter of air.

Aerobiology uses its own internally trained staff to perform the analysis, supported by a highly computerized process to ensure quality and efficiency.

"We know that one of the best defenses against allergy symptoms is regularly taking allergy medication," says Dr. Waserman. "The is a great tool that provides an early-warning system for sufferers so they can act proactively, rather than waiting until the symptoms are already in full effect."



About McNeil Consumer Healthcare (Canada):

McNeil Consumer Healthcare (Canada), Division of Johnson & Johnson Inc., markets a broad range of well known and trusted over the counter (OTC) products, including TYLENOL®, REACTINE®, MOTRIN®, ROLAIDS®, IMODIUM® AND ZANTAC®.

Dr. Susan Waserman is available for interviews to discuss the changing environmental factors that are having a dramatic impact on Canadian allergy sufferers. She can also highlight ways to combat the worsening symptoms.

To view the first photo associated with this release, please visit the following link: .

To view the second photo associated with this release, please visit the following link: .

To view the third photo associated with this release, please visit the following link: .

To view the fact sheet entitled "Non-Drowsy REACTINE® Allergy Fact Sheet," please visit the following link: .

To view the fact sheet entitled "Seasonal Allergies Fact vs. Fiction," please visit the following link: .

To view a bio of Dr. Susan Waserman, please visit the following link: .





Contacts:
To book an interview with Dr. Waserman, to receive images of
the REACTINE® Allergy Forecast or for further information:
GolinHarris for REACTINE®
Meghan Ney
416-642-7957

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Cadus Announces Resignation of Russell Glass as Director Pivotal Therapeutics Inc. Engages US Investor Relations Firm
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 18.08.2011 - 14:31 Uhr
Sprache: Deutsch
News-ID 47967
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, ONTARIO



Kategorie:

Drugs



Diese Pressemitteilung wurde bisher 275 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Putting the Power of Information in the Hands of Allergy Sufferers"
steht unter der journalistisch-redaktionellen Verantwortung von

REACTINE(R) (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Sexual Equality is Needed in Canada's Urban Landscape ...

TORONTO, ONTARIO -- (Marketwire) -- 08/01/12 -- Editors Note: There are 11 infographics, one video, one photo, and one report associated with this press release.There's a battle of the sexes taking place in the plant world and the more than nin ...

Alle Meldungen von REACTINE(R)



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z